Breast Adenocarcinoma Recruiting Phase 3 Trials for Paclitaxel (DB01229)

Also known as: Malignant neoplasm of breast / Malignant breast neoplasm / Breast cancer / Breast tumor malignant / Breast tumour malignant / Breast cancer NOS / Breast cancer stage unspecified / Ca breast

IndicationStatusPhase
DBCOND0029215 (Breast Adenocarcinoma)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03199885Paclitaxel, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Patients With Metastatic Breast CancerTreatment
NCT02488967Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast CancerTreatment